Clinical Trials Directory

Trials / Completed

CompletedNCT02984176

Simethicone: Does it Improve Operative Field and Postoperative Pain?

Simethicone and Gynecological Laparoscopies: Does it Improve Operative Field and Postoperative Pain?

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Woman's Health University Hospital, Egypt · Academic / Other
Sex
Female
Age
20 Years – 40 Years
Healthy volunteers
Not accepted

Summary

Simethicone is an oral anti-foaming agent that reduces bloating, abdominal discomfort, and abdominal pain by promoting the clearance of excessive gas along the gastrointestinal tract. The investigators objective is to evaluate the efficacy and safety of preoperative oral simethicone for bowel preparation in gynecological laparoscopies.

Detailed description

Introduction: Simethicone is an oral antifoaming agent that reduces bloating, abdominal discomfort, and abdominal pain by promoting the clearance of excessive gas along the gastrointestinal tract. Objective: to evaluate the efficacy and safety of preoperative oral simethicone for bowel preparation in gynecological laparoscopies. Methods: 100 infertile women will be scheduled for laparoscopy, patients randomized to receive either Simethicone (Group I) or placebo tablets (Group II). The primary outcome measure will be the overall exposure of the surgical field and pain scoring. Assessment of the overall exposure of the surgical field was done using a five-point scale (poor, sufficient, medium, good, and excellent). Visual analog score (VAS) will be used for assessment of postoperative pain and verbal analog scoring was used for assessment of patient satisfaction.

Conditions

Interventions

TypeNameDescription
DRUGSimethicone Tab 40 mg3 tablets of Simethicone Tab 40 mg (one tablet after each meal) and to fast overnight the day before the operation.
DRUGPlacebo Tablets3 tablets of Placebo Tablets (one tablet after each meal) and to fast overnight the day before the operation.

Timeline

Start date
2014-08-01
Primary completion
2015-07-01
Completion
2015-07-01
First posted
2016-12-06
Last updated
2016-12-07

Source: ClinicalTrials.gov record NCT02984176. Inclusion in this directory is not an endorsement.